Dr. Oz owns stock in companies that supply hydroxychloroquine, the anti-malaria drug he pushed the White House to use as unproven COVID trea
Dr. Oz emailed the White House pushing the anti-malaria drug before trials were completed. Numerous studies found it ineffective at treating
MSN
Dr. Oz emailed the White House in March 2020 promoting an anti-malaria drug to treat COVID-19.
Oz owns stock in two companies that supply the drug, financial disclosures show.
Numerous studies have found hydroxychloroquine ineffective at treating COVID-19.